Cyclization of N -(2-aryl-2-cyclohexen-1-yl)trichloroacetamides by a copper catalyst was investigated. It is crucially important for successful cyclization under mild conditions that alkoxycarbonyl groups are introduced to the nitrogen atom of the N -allyltrichloroacetamides as well as that CuCl(bipyridine) is used as the catalyst. Three compounds, N -(2-phenyl-2-cyclohexen-1-yl)-, N -[2-(3,4-dimethoxyphenyl)-2-cyclohexen-1-yl]-, and N -[2-(3,4-methylenedioxyphenyl)-2-cyclohexen-1-yl]trichloroacetamides, where the Cbz or MeO 2 C− group was attached to the nitrogen atom, were instantly converted to the corresponding trichlorinated cis -3a-aryloctahydroindol-2-ones in high yields at room temperature. The reactions offer a facile access to alkaloid skeletons such as mesembrines and crinines; as the simplest examples, total synthesis of (±)-mesembrane and (±)-crinane was accomplished. The effect of alkoxycarbonyl substituents in the amide group was compared with that of the methyl substituent. N -Methyl- N -(2-phenyl-2-cyclohexen-1-yl)trichloroacetamide quickly reacted in the presence of CuCl(bipyridine) catalyst; however, the products were a mixture of complicated materials including a small amount of the desired lactam. The role of the alkoxycarbonyl group was discussed in terms of rate of rotation of the N−C bond in the N -allyltrichloroacetamides; variable-temperature NMR studies and X-ray structure determination of related compounds were carried out as supporting evidence.
No takes yet. Share an insight, caveat, or question.
Iwamatsu et al. (1999) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: